Approvals/TGA/Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial

Approved

STANDARD

Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d9fc68f476ee3b2c
Product Name: Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial
Artg Id: 17905
Artg Name: ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 1991-09-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/e735478806165feec0852a36971dc4af.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a76086df442d92b70b55c1dd33bea61c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d9fc68f476ee3b2c

Type

Standard